6533b7dbfe1ef96bd1270be3

RESEARCH PRODUCT

Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk

Ramon EstruchJosé LapetraClary B. ClishMarta Guasch-ferréMiguel ÁNgel Martínez-gonzálezLiming LiangCourtney DennisMònica BullóMònica BullóF. ArosF. ArosFrank B. HuFrank B. HuDong D. WangMontserrat FitóEstefanía ToledoEstefanía ToledoMiguel Ruiz-canelaMiguel Ruiz-canelaJun LiDolores CorellaDolores CorellaChristopher PapandreouChristopher PapandreouEmilio RosEmilio RosMiquel FiolLluis Serra-majemLluis Serra-majemYan ZhengJordi Salas-salvadóJordi Salas-salvadó

subject

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical BiochemistryPopulation030209 endocrinology & metabolismContext (language use)Type 2 diabetes030204 cardiovascular system & hematologyDiet MediterraneanBiochemistry03 medical and health sciences0302 clinical medicineEndocrinologyRisk FactorsCarnitineDiabetes mellitusInternal medicineHumansMetabolomicsMedicineProspective StudieseducationClinical Research ArticlesAgedAged 80 and overeducation.field_of_studybusiness.industryProportional hazards modelIncidenceBiochemistry (medical)Hazard ratioCase-control studyfood and beveragesMiddle AgedPrognosismedicine.diseaseEndocrinologyDiabetes Mellitus Type 2ROC CurveCardiovascular DiseasesCase-Control StudiesRelative riskFemalebusinessBiomarkersFollow-Up Studies

description

[Context] The potential associations between acylcarnitine profiles and incidence of type 2 diabetes (T2D) and whether acylcarnitines can be used to improve diabetes prediction remain unclear.

https://doi.org/10.1210/jc.2018-01000